Biodexa Pharmaceuticals (BDRX) Competitors $1.07 -0.03 (-2.73%) Closing price 04:00 PM EasternExtended Trading$1.06 -0.01 (-0.47%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BDRX vs. DERM, TLSA, SGMT, ALMS, EDIT, ACRS, ENTA, SLN, RAPT, and LFVNShould you be buying Biodexa Pharmaceuticals stock or one of its competitors? The main competitors of Biodexa Pharmaceuticals include Journey Medical (DERM), Tiziana Life Sciences (TLSA), Sagimet Biosciences (SGMT), Alumis (ALMS), Editas Medicine (EDIT), Aclaris Therapeutics (ACRS), Enanta Pharmaceuticals (ENTA), Silence Therapeutics (SLN), RAPT Therapeutics (RAPT), and LifeVantage (LFVN). These companies are all part of the "pharmaceutical products" industry. Biodexa Pharmaceuticals vs. Its Competitors Journey Medical Tiziana Life Sciences Sagimet Biosciences Alumis Editas Medicine Aclaris Therapeutics Enanta Pharmaceuticals Silence Therapeutics RAPT Therapeutics LifeVantage Biodexa Pharmaceuticals (NASDAQ:BDRX) and Journey Medical (NASDAQ:DERM) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and dividends. Does the media prefer BDRX or DERM? In the previous week, Journey Medical had 1 more articles in the media than Biodexa Pharmaceuticals. MarketBeat recorded 4 mentions for Journey Medical and 3 mentions for Biodexa Pharmaceuticals. Journey Medical's average media sentiment score of 0.54 beat Biodexa Pharmaceuticals' score of 0.30 indicating that Journey Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Biodexa Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Journey Medical 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of BDRX or DERM? 17.5% of Biodexa Pharmaceuticals shares are owned by institutional investors. Comparatively, 7.3% of Journey Medical shares are owned by institutional investors. 0.3% of Biodexa Pharmaceuticals shares are owned by company insiders. Comparatively, 15.0% of Journey Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community believe in BDRX or DERM? Journey Medical received 6 more outperform votes than Biodexa Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Biodexa Pharmaceuticals an outperform vote while only 87.50% of users gave Journey Medical an outperform vote. CompanyUnderperformOutperformBiodexa PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo VotesJourney MedicalOutperform Votes787.50% Underperform Votes112.50% Which has better valuation & earnings, BDRX or DERM? Journey Medical has higher revenue and earnings than Biodexa Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiodexa Pharmaceuticals$83K471.11-$7.66MN/AN/AJourney Medical$56.24M2.81-$3.85M-$0.39-17.38 Do analysts recommend BDRX or DERM? Journey Medical has a consensus price target of $9.88, indicating a potential upside of 45.65%. Given Journey Medical's stronger consensus rating and higher probable upside, analysts clearly believe Journey Medical is more favorable than Biodexa Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodexa Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Journey Medical 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Which has more volatility & risk, BDRX or DERM? Biodexa Pharmaceuticals has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500. Comparatively, Journey Medical has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Is BDRX or DERM more profitable? Biodexa Pharmaceuticals has a net margin of 0.00% compared to Journey Medical's net margin of -31.74%. Biodexa Pharmaceuticals' return on equity of 0.00% beat Journey Medical's return on equity.Company Net Margins Return on Equity Return on Assets Biodexa PharmaceuticalsN/A N/A N/A Journey Medical -31.74%-132.10%-26.90% SummaryJourney Medical beats Biodexa Pharmaceuticals on 10 of the 17 factors compared between the two stocks. Get Biodexa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BDRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BDRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BDRX vs. The Competition Export to ExcelMetricBiodexa PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$39.10M$6.88B$5.58B$8.50BDividend YieldN/A2.53%5.28%4.17%P/E RatioN/A8.5527.1919.64Price / Sales471.11262.61408.78152.17Price / CashN/A65.8538.3234.64Price / Book0.036.536.974.60Net Income-$7.66M$143.48M$3.23B$248.06M7 Day Performance-6.96%0.20%-0.88%-1.02%1 Month Performance-17.05%10.93%7.81%3.51%1 Year PerformanceN/A2.46%31.53%12.68% Biodexa Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BDRXBiodexa Pharmaceuticals0.48 of 5 stars$1.07-2.7%N/AN/A$39.10M$83K0.0020Short Interest ↑DERMJourney Medical2.2854 of 5 stars$7.16-3.1%$9.88+37.9%+17.3%$166.80M$56.24M-7.6290Positive NewsShort Interest ↑TLSATiziana Life Sciences1.3674 of 5 stars$1.42-0.7%N/A+74.0%$165.92MN/A0.008News CoveragePositive NewsGap UpSGMTSagimet Biosciences2.3657 of 5 stars$5.33-4.1%$23.17+334.6%+61.2%$163.50M$2M-3.038ALMSAlumis2.8633 of 5 stars$3.43-4.5%$24.86+624.7%N/A$161.97M$17.39M0.00N/APositive NewsUpcoming EarningsAnalyst UpgradeAnalyst RevisionEDITEditas Medicine4.229 of 5 stars$1.93+1.0%$5.36+177.9%-63.9%$161.57M$35.84M-0.75230Positive NewsAnalyst RevisionGap DownACRSAclaris Therapeutics2.6786 of 5 stars$1.49-2.6%$9.71+552.0%+33.0%$161.34M$17.78M-2.87100ENTAEnanta Pharmaceuticals3.7356 of 5 stars$7.50+0.4%$18.00+140.0%-44.3%$160.33M$64.46M-1.52160Positive NewsSLNSilence Therapeutics3.0617 of 5 stars$5.31-2.4%$33.83+537.2%-73.1%$158.93M$27.70M-3.38100News CoveragePositive NewsAnalyst ForecastGap UpRAPTRAPT Therapeutics4.024 of 5 stars$1.20+2.6%$3.00+150.0%-69.3%$158.75M$1.53M-0.4380News CoverageLFVNLifeVantage4.0151 of 5 stars$12.49-0.2%$30.50+144.2%+72.3%$157.22M$222.35M22.30260Positive News Related Companies and Tools Related Companies Journey Medical Competitors Tiziana Life Sciences Competitors Sagimet Biosciences Competitors Alumis Competitors Editas Medicine Competitors Aclaris Therapeutics Competitors Enanta Pharmaceuticals Competitors Silence Therapeutics Competitors RAPT Therapeutics Competitors LifeVantage Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BDRX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodexa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BDRX Stock Free BDRX Stock Alerts